Innovative ultrasonic technology to produce biodegradable microcapsules for encapsulating hydrophobic active ingredients using sustainable biopolymers, offering controlled release, high loading capacity, and protection against degradation.
The proposed solution utilizes ultrasonic technology to fabricate biodegradable microcapsules designed for the encapsulation of hydrophobic active ingredients such as nutrients, pesticides, and drugs. This innovative process employs cost-effective, abundant biopolymers like raw egg white proteins, green tea catechins, soy, and corn proteins as shell materials. The technology ensures that the encapsulation process is environmentally friendly, avoiding toxic crosslinkers and organic solvents. The resulting microcapsules boast high loading capacity, biocompatibility, and bioactivity, providing controlled release and protection against environmental degradation.
Key features:
This technology is currently at TRL 4, with successful lab-scale demonstration of core-shell microcapsules using ultrasonic fabrication. The next steps include optimizing materials and parameters for scalable production, with plans to validate at pilot scale within one year.
The University of Melbourne is a comprehensive institution spanning STEM, health and clinical practice, business and law, and the creative and social disciplines. Co‑located hospital and research precincts, together with an inner‑city innovation ecosystem, place companies, startups, and researchers in shared labs, prototyping spaces, and studios. Engineering and technology programs connect with advanced manufacturing facilities, while structured industry projects and placements link partners with talent and translational problem‑solving. Work is supported by competitive funding from the Australian Research Council and the National Health and Medical Research Council, with additional backing from state programs and industry partners; a dedicated technology transfer office manages IP, licensing, and startup formation.